Combination immunotherapy before surgery may increase survival in people with head and neck cancer: Clinical trial
Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...
CURE11d
My Journey With Squamous Cell Carcinoma
A patient shares his experience with a squamous cell carcinoma diagnosis, treatment and recovery. It was a Friday afternoon, ...
Targeted Oncology19h
Kato Breaks Down FDA Approval of Tislelizumab in Esophageal Cancer
Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.
Raleigh TV meteorologist paused on-air work for cancer treatment. Update on when he returns
The longtime local news meteorologist has been temporarily absent from broadcasts as he manages his health, but he’ll be back ...
MyChesCo on MSN1d
Aprea Therapeutics Teams Up with MD Anderson for Preclinical HNSCC Research
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) has entered into a Material Transfer Agreement (MTA) with MD ...
Medscape2d
Low-Dose CT Vs Chest X-Ray for Lung Cancer Surveillance in HNSCC: Is One Better?
When diagnosing lung metastases and second primary lung cancer in patients with head and neck cancer, low-dose CT leads to better sensitivity than chest x-ray but does not lead to improved overall ...
HealthDay on MSN2d
ASTRO Issues Clinical Guideline for Use of Radiation Therapy in Anal Cancer
In a clinical practice guideline issued by the American Society for Radiation Oncology and published online Feb. 27 in ...
Managed Healthcare Executive9d
FDA Approves Tevimbra for Advanced Esophageal Cancer at $15,828 Per Month
Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...
CURE10d
FDA Approves Tevimbra Plus Chemotherapy For Some With Esophageal Cancer
The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma ...